DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Japan
  • /
  • Tech
Author Program NEWCreate Narrative
6856 logo

HORIBA, Ltd. Stock Price

TSE:6856 Community·JP¥919.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

6856 Share Price Performance

JP¥0
-11785.00 (-100.00%)
​
JP¥0
-11785.00 (-100.00%)
​
Price JP¥0
Thu, 10 Sep 26
Share Pricen/a

6856 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record and pays a dividend.

2 Risks
3 Rewards
View Full Analysis

HORIBA, Ltd. Key Details

JP¥364.0b

Revenue

JP¥203.5b

Cost of Revenue

JP¥160.5b

Gross Profit

JP¥117.4b

Other Expenses

JP¥43.0b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 13, 2026
1.02k
44.09%
11.82%
17.2%
View Full Analysis

About 6856

Founded
1945
Employees
9101
CEO
Masayuki Adachi
WebsiteView website
www.horiba.com/int/

HORIBA, Ltd., together with its subsidiaries, provides analytical and measurement solutions in Japan, Asia, the United States, and Europe. It operates in three segments: Energy and Environment; Bio and Healthcare; and Advanced Materials and Semiconductor. The company offers mobility products, including systems for emissions measurement, internal combustion engine testing, driveline and powertrain evaluation, brake testing, and wind tunnels; and energy and environment solutions for water and liquid, industrial process, and energy. It also provides life science products comprising fluorescence spectroscopy, raman imaging and spectrometers, and particle characterization; healthcare solutions, which include vitro diagnostic systems for biological analysis, clinical chemistry, veterinary, hematology, and hemostasis; material analysis, such as elemental analysis, molecular and structural analysis, and surface analysis and thin film characterization; and semiconductor products. In addition, the company offers technology solutions comprising health care, fluid control, mass spectrometry, spectroscopy, microscopy and imaging, electrochemistry, physisorption, particle and element analysis, and surface plasmon resonance; and services, including analysis centers, calibration and certification, customer support, spare parts and consumables, testing and consulting, and product and technology training. Its products are used in arts, entertainment, and recreation; biopharma and pharma, biotechnology and biomedical; cosmetics; education, research and development, and government institution; energy solutions; food and beverage; healthcare; industrials; information technology; materials; mobility and transportation; waste management; and water applications. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.

Recent 6856 News & Updates

Recent updates

No updates

HORIBA, Ltd. Competitors

6861 logo

Keyence

Symbol: TSE:6861
Market cap: JP¥18.5t
6981 logo

Murata Manufacturing

Symbol: TSE:6981
Market cap: JP¥13.0t
4062 logo

IbidenLtd

Symbol: TSE:4062
Market cap: JP¥6.0t
6762 logo

TDK

Symbol: TSE:6762
Market cap: JP¥5.3t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide